The Women's Tennis Association will require all players to undergo genetic sex testing in order to compete on the women's tour, according to reports from the BBC and Sky Sports.
Key facts
- The WTA is to require all players to undergo genetic sex testing to compete on the WTA Tour, according to the BBC.
- Sky Sports also reported that players will have to undergo genetic sex testing to play on the women's tour.
- Sky Sports' report referred to an SRY gene test as the method used to determine a player's sex.
- Both outlets reported the development on 20 July 2026.
The Women’s Tennis Association is to ask all players to undergo genetic sex testing in order to compete on the WTA Tour, according to the BBC.
Sky Sports similarly reported that the WTA has announced players will have to undergo genetic sex testing to play on the women’s tour. Sky Sports’ report referred to the requirement as an SRY gene test used to determine a player’s sex.
Both outlets reported the development on 20 July 2026.
The measure, as reported, would apply to all players seeking to compete on the women’s tour, making the genetic test a condition of participation.
Beyond the reports that testing will be introduced, the available sources do not specify a start date, how the tests will be administered, or how results will be handled.
Why it matters
Eligibility rules based on genetic sex testing are among the most closely watched and contested issues in professional sport. A mandatory requirement across an entire tour could affect who is able to compete.
Frequently asked questions
What test will WTA players have to take?
According to Sky Sports, players will have to undergo a genetic sex test described as an SRY gene test to determine their sex in order to compete.
Who does the requirement apply to?
The sources state the testing requirement applies to all players seeking to compete on the WTA women's tour.
When was this announced?
The requirement was reported by the BBC and Sky Sports on 20 July 2026.